The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Dr. Lbiati's appointment signals a new chapter for Hepion-one focused on strategic renewal, value creation, and diagnostic ...

The reluctance to get childhood immunizations comes amid a tumultuous period in Washington surrounding vaccine approvals.

The reluctance to get childhood immunizations comes amid a tumultuous period in Washington surrounding vaccine approvals.

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...

Moderna said the Food and Drug Administration expanded its approval of the pharmaceutical company's respiratory syncytial virus vaccine, mResvia, to adults aged 18-59 at increased risk for the disease ...

The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first ...

Novavax NVAX announced encouraging results from an initial cohort of a late-stage study evaluating its experimental ...

Primary sclerosing cholangitis, PSC in short, is a rare liver disease that destroys the bile ducts. It is a severe condition ...

When it comes to vaccines, where they go into your body can make a surprising difference in how well they work. Scientists in ...